Abstract:Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, with proto-oncogene, receptor tyrosine kinase (c-kit), or PDGFRα mutations detected in around 85% of cases. GISTs without c-kit or platelet-derived growth factor receptor alpha (PDGFRα) mutations are considered wild-type (WT), and their diverse molecular alterations and biological behaviors remain uncertain. They are usually not sensitive to tyrosine kinase inhibitors (TKIs). Recently, some molecular alterations, including neurotrophic tyrosine receptor kinase (NTRK) fusions, have been reported in very few cases of WT GISTs. This novel finding opens the window for the use of tropomyosin receptor kinase (TRK) inhibitor therapy in these subtypes of GIST. Herein, we report a new case of NTRK-fused WT high-risk GIST in a female patient with a large pelvic mass (large dimension of 20 cm). The tumor was removed, and the histopathology displayed spindle-predominant morphology with focal epithelioid areas, myxoid stromal tissue, and notable lymphoid infiltration with tertiary lymphoid structures. Ten mitoses were quantified in 50 high-power fields without nuclear pleomorphism. DOG1 showed strong and diffuse positivity, and CD117 showed moderate positivity. Succinate dehydrogenase subunit B (SDHB) was retained, Pan-TRK was focal positive (nuclear pattern), and the proliferation index Ki-67 was 7%. Next-generation sequencing (NGS) detected an ETV6::NTRK3 fusion, and this finding was confirmed by fluorescence in situ hybridization (FISH), which showed NTRK3 rearrangement. In addition, an RB1 mutation was found by NGS. The follow-up CT scan revealed peritoneal nodules suggestive of peritoneal dissemination, and Entrectinib (a TRK inhibitor) was administered. After 3 months of follow-up, a new CT scan showed a complete response. Based on our results and the cases from the literature, GISTs with NTRK fusions are very uncommon so far; hence, further screening studies, including more WT GIST cases, may increase the possibility of finding additional cases. The present case may offer new insights into the potential introduction of TRK inhibitors as treatments for GISTs with NTRK fusions. Additionally, the presence of abundant lymphoid infiltration in the present case may prompt further research into immunotherapy as a possible additional therapeutic option.

Identification of a Novel FGFR2-KIAA1217 Fusion in Esophageal Gastrointestinal Stromal Tumours: A Case Report

Endoscopic Treatment Can Be a Viable Therapeutic Option for Esophageal Gastrointestinal Stromal Tumors

Esophageal Granular Cell Tumors：report of 9 Cases and a Literature Review

A Novel Fusion between CDC42BPB and ALK Exon 20 in a Patient with Wild Type Gastrointestinal Stromal Tumor: a case report

A Novel Fusion Between CDC42BPB and ALK in a Patient with Quadruple Wild‐type Gastrointestinal Stromal Tumor

A Rare Case of Rapid Growth of Exophytic Gastrointestinal Stromal Tumor of the Stomach

EGFR Gene Mutation in Gastrointestinal Stromal Tumours.

Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation

Chinese Pedigree with Hereditary Gastrointestinal Stromal Tumors: A Case Report and Literature Review

Gastrointestinal stromal tumor with PDGFRA exon 18 mutation:a case report and review of the literature.

Long-term Survival after Enucleation of a Giant Esophageal Gastrointestinal Stromal Tumor.

FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumor

A Giant Gastrointestinal Stromal Tumor of the Stomach Presenting As a Posterior Mediastinal Mass.

Gastrointestinal Stromal Tumor of Esophageal Location: A Rare Case with Surgical Discussion. Case Report and Literature Review

A Report on a New Case with Therapeutic Implications and a Literature Review

Two different mutational types of familial gastrointestinal stromal tumors: Two case reports

FGFR2-TSC22D1, a Novel FGFR2 Fusion Gene Identified in a Patient with Colorectal Cancer: A Case Report.

Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion

FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors

Surgery for multiple gastric gastrointestinal stromal tumors and large esophageal diverticulum related to germline mutation of the KIT gene: a case report

Whole-exome sequencing analysis of mutation characteristics in recurrent or metastatic gastrointestinal stromal tumors